Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Molecular pathogenesis of the myeloproliferative neoplasms

Fig. 1

MPN Heterogeneity. A figure demonstrating the distinct clinical entities observed in MPN patients with a summary of distinguishing clinical features observed in each. *Propensity to enhanced rates of clot formation in ET appear to be variable depending on driver mutation status. **Bleeding can manifest in a minority of ET patients resulting from acquired Von Willebrand disease resulting from very high platelet counts

Back to article page